Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Topadur Pharma | 2024 | Series Unknown | $3.4M | Schlieren |
| GaitQ | 2024 | Grant | Undisclosed | Oxford |
| LEDCity | 2024 | Series Unknown | $2.2M | Zürich |
| Spirecut | 2024 | Series A | $800K | Muttenz |
| Hemotune | 2024 | Series B | $15.6M | Schlieren |
| Volumina Medical | 2024 | Series A | $21.0M | Epalinges |
| Terapet | 2024 | Grant | $1.8M | Geneva |
| FimmCyte | 2024 | Convertible Note | $1.1M | Basel |
| Galventa | 2023 | Seed | $1.8M | Saint Gallen |
| Scailyte | 2023 | Series A | $1.8M | Basel |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 176 | Topadur Pharma | Series Unknown | $3.4M | Schlieren, Switzerland |
| 177 | GaitQ | Grant | Undisclosed | Oxford, United Kingdom |
| 178 | LEDCity | Series Unknown | $2.2M | Zürich, Switzerland |
| 179 | Spirecut | Series A | $800K | Muttenz, Switzerland |
| 180 | Hemotune | Series B | $15.6M | Schlieren, Switzerland |
| 181 | Volumina Medical | Series A | $21.0M | Epalinges, Switzerland |
| 182 | Terapet | Grant | $1.8M | Geneva, Switzerland |
| 183 | FimmCyte | Convertible Note | $1.1M | Basel, Switzerland |
| 184 | Galventa | Seed | $1.8M | Saint Gallen, Switzerland |
| 185 | Scailyte | Series A | $1.8M | Basel, Switzerland |
Topadur Pharma is a biopharmaceutical company that develops healthcare drugs for the treatment of aging diseases and medical ailments.
gaitQ® develops innovative wearable technology that improves people’s mobility and quality of life.
LEDCity is a energy technology company that designs and develops efficient lighting systems for commercial buildings.
Spirecut is a medtech company that democratizes minimally invasive surgery with ultrasound guided instruments
Hemotune is a medical device company that develops a therapeutic blood purification platform for the treatment of health ailments.
Volumina Medical is a healthcare technology company that engages develops injectable 3D scaffolds for the reconstruction of soft tissues.
Geneva-based MedTech spin-off from CERN, specializing in the development and manufacturing of innovative nuclear imaging systems.
FimmCyte is a biotechnology company that engages in the research and treatment of chronic endometriosis disease.
Galventa provides pharmaceutical manufacturing services for a micro-pellet-based food supplement that relieves sleep inertia symptoms.
True precision medicine through single-cell science
GRZ Technologies is a company active in the field of renewable energy storage.
MPC Therapeutics develops a class of compounds with applications in immunotherapy and metabolic diseases.
Ascento designs a compact wheeled jumping robot for enhanced security in various environments.
TissueLabs is a biotechnology research company that operates a platform for creating organs and tissues in the lab.
Atinary is an end-to-end AI, machine learning, robotics, and cloud computing technology platform for digitizing R&D operations.
AI Customer Service Platform for Enterprises
Automating submerged asset inspections with a remote underwater drone platform
SEED is a spinoff from the Swiss Federal Institute of Technology.
Komed Health is a healthcare collaboration platform that streamlines clinical workflows.
T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.
Riskwolf is an insurance platform that provides risk management and data protection services.
Remote sensing satellite data processing with artificial intelligence for energy production optimization
PIPRA is developing a cutting-edge AI-based pre-surgical tool to assess patients’ risk of suffering from cognitive impairment after surgery.
carecircle is the world's first global independent hyperscale social network and platform for health and wellness.
We engineered the first injectable biomaterial that stimulated the body's natural ossification process for rapid bone repair & strengthening
Innosuisse has invested in 211 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Innosuisse's top investment sectors include Health Care, Biotechnology, Medical, Medical Device, Life Science. The firm invests across 47 different industry categories.
Among tracked funding rounds, Volumina Medical received $21.0M in a Series A round. Innosuisse's total known invested capital is $569.8M.
Innosuisse's average investment size is $3.2M across its portfolio of 211 companies.
Recent Innosuisse portfolio additions include Topadur Pharma, GaitQ, LEDCity, Spirecut, Hemotune. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors